| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 41 | Improved liniment for rheumatism | US40686D | US40686A | 1863-11-24 | ||
| 42 | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same | US241692 | 1994-05-12 | US5888984A | 1999-03-30 | Harold G. Brown |
| The invention discloses the discovery that a pharmaceutical composition containing complex carbohydrates and natural or synthetic essential oils can work effectively as a topical pharmaceutical composition. Such pharmaceutical compositions reduce inflammation, assist in wound healing, protect against bruising, relieve itching, relieve pain and swelling and treat topical bacterial infections such as acne and decubitus ulcers. Such pharmaceutical compositions can be administered to mammals including humans. Also included in this invention are methods to deliver topically applied macromolecules into the tissue of mammals and methods of blocking the adhesion cascade. | ||||||
| 43 | Veterinary topical compositions and methods of use | US800563 | 1997-02-18 | US5741527A | 1998-04-21 | Paul K. Brown |
| The present invention relates to novel veterinary topical compositions, methods of making the compositions, and methods of using the compositions in the treatment of bone, muscle and connective tissue injuries, as well as respiratory ailments, in animals, particularly horses, dogs, and goats. The compositions comprise isopropyl alcohol, mercuric chloride and dimethylsulfoxide (DMSO), and may further comprise herbs. Light training can typically be resumed beginning about 24 hours after applying the composition to the injured area of the animal. | ||||||
| 44 | Method for inhibiting growth of helicobacter pylori | US266013 | 1994-06-27 | US5560912A | 1996-10-01 | Itzhak Neeman; Mina Tabak; Robert Armon |
| The invention relates to the use of an organic extract of the plant Cinnamon or a chemical constituent present in said plant, to prepare a pharmaceutical composition useful to inhibit the growth of Helicobacter pylori and the urease activity of Helicobacter pylori. Most preferred chemical constituents are cinnamaldehyde and methoxycinnamaldehyde. The extract may be used either as a drink, with or without additional flavoring ingredients or transformed into a capsule. The invention also relates to in-vitro method for determininig the inhibition of urease activity of Helicobacter pylori using said organic extract of the plant or chemical constituents present in said plant. | ||||||
| 45 | Virus inhibiting composition | US969208 | 1993-01-27 | US5554596A | 1996-09-10 | Walter Mach, deceased; by Chantal Mach, executor |
| A composite molecular active substance group for use in restitutive chemotherapy against viral infections, which is produced by the process comprising: (a) preparing lignin units by carrying out an extraction in an aqueous media under weakly acidic or alkaline conditions of wood or wood-like materials and/or plant-cell cultures and separating-off the resultant insoluble solids; (b) preparing lignoid units by carrying out an aqueous alkaline extraction at a pH of 7 to 14 of starting materials selected from the group consisting of wood-incarbonization products and bioconverted wood-like materials and separating-off the resultant alkali-insoluble solids; and (c) preparing a water-soluble mixed polymer by reacting the lignin units from step (a) with the lignoid units from step (b), under aqueous alkaline isolating by ultrafiltration a low molecular weight fraction having a molecular weight of no more than 3000 daltons of the mixed polymer, taking a cut between 15 to 40 kilodaltons and discarding the resultant residue, and treating the resultant solution with an H.sup.+ cation exchanger at a pH of 3 to 7 and then carrying out further processing. | ||||||
| 46 | Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis | US53665 | 1993-04-29 | US5348959A | 1994-09-20 | Che-Ming Teng; Chien-Chih Chen; Sheu-Meei Yu |
| A method for the treatment of hypertension, arrhythmia, thrombosis or/and atherosclerosis with an effective amount of dicentrine or other alkaloids extracted from Lindera oldhammii (megaphylla) Hemsl. | ||||||
| 47 | Appetite suppressant composition and method relating thereto | US857571 | 1992-03-27 | US5273754A | 1993-12-28 | Morris A. Mann |
| There is disclosed an appetite suppressant composition for oral administration. The composition includes a heating and a cooling carminative substance, and may also include an amino acid and an anxiolytic substance. Also disclosed are methods for decreasing appetite by oral administration of the appetite suppressant composition, and for manufacture of the appetite suppressant composition. | ||||||
| 48 | Use of dicentrine and its derivatives for the treatment of arrhythmia | US944235 | 1992-09-14 | US5270321A | 1993-12-14 | Ming-Jai Su |
| A method of arrhythmia with an effective amount of dicentrine or other alkaloids extracted from Lindera oldhammii (megaphylla) Hemsl. | ||||||
| 49 | Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis | US801275 | 1991-12-02 | US5262421A | 1993-11-16 | Ming-Jai Su; Chien-Chih Chen; Che-Ming Teng; Sheu-Meei Yu |
| A method for the treatment of hypertension, arrhythmia, thrombosis or/and atherosclerosis with an effective amount of dicentrine or other alkaloids extracted from Lindera oldhammii (megaphylla) Hemsl. | ||||||
| 50 | Hardening agent for affected tissues of the digestive system | US690762 | 1991-04-24 | US5252344A | 1993-10-12 | Zhao-Qi Shi |
| The hardening agent contains a composition comprised of tannic acid and potassium aluminum sulfate in a ratio of tannic acid to potassium aluminum sulfate ranging from 10 to 1 to 1 to 50 and a stabilizing agent extracted from crude drugs of plants containing a phenol, flavon, flavonoid, catechin or a polycarboxylic acid. | ||||||
| 51 | Pharmaceutical liquid composition containing bezoar bovis and preparation for its manufacture | US595673 | 1990-10-11 | US5190757A | 1993-03-02 | Young S. Kim |
| A pharmaceutical liquid composition prepared by combining a predetermined quantity of natural substances from the genera Glycyrrhizae Radix, Ginseng Radix, Typhae Pollen, Massa Medicata Fermentata, Sojae germinatum Semen, Cinnamomi Cortex, Gelatin, Paeoniae Radix, Liriope Tuber, Scutellariae Radix, Angelicae Gigantis Radix, Ledebouriellae Radix, Atractylodis Rhizoma Alba, Bupleuri Radix, Platycodi Radix, Armeniacae Semen, Hoelen, Cnidii Rhizoma, Antellopis Cornu, Ampelopsis Radix, Zingiberis Rhizoma, Dioscoreae Rhizoma, Cinnabaris, Realgar, Aurum, and Mel and cutting the natural substances into microparticle size or extracting the natural substances with water to form a first product; providing a predetermined quantity of natural substances from the genera Bezoar Bovis, Moschus, and Rhinocerotis; cutting the natural substances into a microparticle size and extracting with water or alcohol to form a second product; providing a genus Gelatin solution; providing a genus Borneol solution; mixing the first and second products and the Gelatin and Borneol solutions to form a mixture; and preparing the mixture with water to produce a pharmaceutical liquid composition for orally administering to patients such as infants, children, critical patients, and the like. | ||||||
| 52 | Process for the preparation of pharmaceutical liquid composition containing Bezoar bovis | US821816 | 1992-01-17 | US5164184A | 1992-11-17 | Young S. Kim |
| A process for preparing a pharmaceutical liquid composition for orally administrating to patients such as infants, children, critical patients, and the like, which comprises the steps of (a) extracting a first microparticle mixture of Dioscoreae rhizoma, Glycyrrhizae radix, Ginseng radix, Typhae pollen, Massa medicata fermentata, Sojae germinatum semen, Cinnamomi cortex, Paeoniae radix, Liriope tuber, Scutellariae radix, Angelicae gigantis radix, Ledebouriellae radix, Atractylodis rhizoma alba, Bupleuri radix, Platycodi radix, Armeniacae semen, Hoelen, Cnidii Rhizoma, Antellopis cornu, Ampelopsis radix, and Zingiberis rhizoma with water to provide a first extract and filtering the first extract to provide a first filtrate, (b) grinding Bezoar bovis and moschus and passing each ground powder to produce a Bezoar bovis powder and a moschus powder, respectively, (c) solving Borneol with ethanol to produce a Borneol-ethanol solution, (d) solving Gelatin with warm water to produce a Gelatin solution, and (3) combining the first filtrate, the Bezoar bovis and moschus powders, the Borneol-ethanol solution and, the Gelating solution. | ||||||
| 53 | Process for preparing ferulic acid | US63433 | 1987-06-18 | US4945115A | 1990-07-31 | Yaguang Liu |
| A new pharmaceutical composition for treatment and prevention of side effects of anticancer chemotherapy and radiotherapy and increasing the immune function contains Ferulic acid, Ginsenoside, Anethole and sodium Cinnamate. Processes for producing these components and related pharmacological effect are provided. | ||||||
| 54 | Composition for relief and treatment of hemorrhoids | US923877 | 1986-10-28 | US4761285A | 1988-08-02 | Anna Vasiliou; Athanasios Vasiliou |
| A composition comprising Leptandra Culver's root, chick-peas and grape seeds. The composition can be enhanced with honey, cinnamon and/or oil. The composition is useful for the relief and treatment of hemorrhoids and hemorrhoidal symptoms. The composition can also be used as an herbal food supplement for dietary and nutritional purposes. | ||||||
| 55 | Veterinary-sauce prophylactic | US605194 | 1984-04-30 | US4702914A | 1987-10-27 | Hillary A. Ryan |
| In a preferred embodiment there is provided for application to ordinary pet food for dogs, cats, puppies and kittens, a dietary ketchup sauce inclusive of garlic as a prophylactic against flea infestation and of diethyl-carbamazine as a prophylactic against mosquito heart-worm, and further inclusive of vitamins and minerals of dietary nature, dietary seed, salt, and honey. | ||||||
| 56 | Preparation for deactivating viruses and process for producing same | US398705 | 1982-07-15 | US4592910A | 1986-06-03 | Erich Wolf; Andreas Lembke; Rolf Deininger |
| The invention relates to a process and a preparation for deactivating viruses inside living human and animal organisms by application of a terpene obtainable from aromatic plants by steam distillation. The terpenes cited are: black pepper oil, cinnamon flower oil, cardamon oil, linallyl acetate, cinnamic aldehyde, safrol, carvon and cis/trans citral. | ||||||
| 57 | Veterinary composition and method of using same | US422363 | 1982-09-23 | US4443437A | 1984-04-17 | Walter G. Prokosch; Robert L. Marshall |
| This invention relates to a topical veterinary composition and a method of using same for the treatment of flesh wounds or lacerations or fistulas in animals and to promote the healing thereof. The composition comprises as the active ingredient tall oil either per se or as a topical veterinary ointment comprising the active ingredient in admixture with a suitable carrier and/or antiseptic. | ||||||
| 58 | Method for manufacturing a tonic composition for man and other animals | US658813 | 1976-02-17 | US4059695A | 1977-11-22 | Kanari Hirosaki; Shin Hirosaki |
| This invention relates to a method for a manufacture of a tonic composition for man and other animals, which method comprises dissolving effective components extracted from comfrey leaves and leaves of one or more plants by refined wood vinegar and refining the solution, wherein the extracted component and the refined wood vinegar have synergistic effects for activating bodies of man and other animals. | ||||||
| 59 | Shelf stable multi-use composition, preparation and use | US44163174 | 1974-02-11 | US3923984A | 1975-12-02 | ZUERCHER CARL J |
| An improved multi-use composition having shelf stability of at least 6 months and suitable for use as a pain reliever, burn healing agent, antiphlogistic and for the treatment of canker sores and the like is disclosed. The multi-use composition may be prepared by the addition of particular, separately prepared, solutions to an aqueous camphor solution.
|
||||||
| 60 | Ocotea alkaloid for relief of anxiety | US30184172 | 1972-10-30 | US3900564A | 1975-08-19 | FERRARI GIORGIO; CASAGRANDE CESARE |
| Crystalline glaziovine having the formula:
AND ITS ACID ADDITION SALTS HAVE PSYCHOTROPIC PROPERTIES USEFUL IN THERAPEUTIC COMPOSITIONS FOR THE RELIEF OF ANXIETY. The alkaloid is obtained by extraction of the bark and leaves of the genus Ocotea (Lauraceae), species glaziovii. |
||||||
QQ群二维码
意见反馈
意见反馈